GSK3β-dependent phosphorylation alters DNA binding, transactivity and half-life of the transcription factor USF2.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 4169611)

Published in PLoS One on September 19, 2014

Authors

Tina Horbach1, Tabughang Franklin Chi2, Claudia Götz3, Satyan Sharma2, André H Juffer2, Elitsa Y Dimova2, Thomas Kietzmann2

Author Affiliations

1: Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, Oulu, Finland; Department of Chemistry, University of Kaiserslautern, Kaiserslautern, Germany.
2: Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, Oulu, Finland.
3: Medical Biochemistry and Molecular Biology, Saarland University, Homburg, Germany.

Articles cited by this

Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27

VMD: visual molecular dynamics. J Mol Graph (1996) 117.02

Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem (1996) 45.70

I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc (2010) 22.66

I-TASSER server for protein 3D structure prediction. BMC Bioinformatics (2008) 18.28

beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J (1997) 12.97

Canonical sampling through velocity rescaling. J Chem Phys (2007) 12.40

GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics (2013) 11.01

Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature (2000) 8.37

A vector for expressing GAL4(1-147) fusions in mammalian cells. Nucleic Acids Res (1989) 8.06

The renaissance of GSK3. Nat Rev Mol Cell Biol (2001) 7.99

The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci (2004) 7.92

GSK3 takes centre stage more than 20 years after its discovery. Biochem J (2001) 7.74

The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer. Genes Dev (1990) 6.88

Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat Protoc (2006) 6.24

Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J Clin Invest (1998) 4.85

Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res (1996) 4.79

Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos. Nature (1995) 4.14

Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem J (1994) 3.62

Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3beta. Genes Dev (2004) 2.94

Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells. Nucleic Acids Res (1994) 2.27

Genetic alterations in hormone-refractory recurrent prostate carcinomas. Am J Pathol (1998) 1.97

Interactions of coiled coils in transcription factors: where is the specificity? Curr Opin Genet Dev (1993) 1.94

Ordered multisite protein phosphorylation. Analysis of glycogen synthase kinase 3 action using model peptide substrates. J Biol Chem (1990) 1.88

A role of DNA-PK for the metabolic gene regulation in response to insulin. Cell (2009) 1.84

Upstream stimulating factors: highly versatile stress-responsive transcription factors. Pigment Cell Res (2005) 1.71

What Are the bona fide GSK3 Substrates? Int J Alzheimers Dis (2011) 1.65

Functional domains of the transcription factor USF2: atypical nuclear localization signals and context-dependent transcriptional activation domains. Mol Cell Biol (1996) 1.65

Immunochemical characterization and transacting properties of upstream stimulatory factor isoforms. J Biol Chem (1996) 1.64

PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer. Oncogene (2006) 1.59

The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors. PLoS Genet (2009) 1.57

Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner. Mol Cell Biol (2007) 1.54

Overlapping roles and asymmetrical cross-regulation of the USF proteins in mice. Proc Natl Acad Sci U S A (1998) 1.47

Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword? Biochem Soc Trans (2004) 1.45

Cell cycle and developmental regulations of replication factors in mouse embryonic stem cells. J Biol Chem (2005) 1.43

Cell-type-dependent activity of the ubiquitous transcription factor USF in cellular proliferation and transcriptional activation. Mol Cell Biol (1999) 1.40

Antiproliferative properties of the USF family of helix-loop-helix transcription factors. Proc Natl Acad Sci U S A (1996) 1.30

The Usf-1 transcription factor is a novel target for the stress-responsive p38 kinase and mediates UV-induced Tyrosinase expression. EMBO J (2001) 1.23

Upstream stimulatory factor proteins are major components of the glucose response complex of the L-type pyruvate kinase gene promoter. J Biol Chem (1995) 1.21

The helix-loop-helix containing transcription factor USF binds to and transactivates the promoter of the p53 tumor suppressor gene. Nucleic Acids Res (1993) 1.19

A Fenton reaction at the endoplasmic reticulum is involved in the redox control of hypoxia-inducible gene expression. Proc Natl Acad Sci U S A (2004) 1.17

GSK-3β regulates cell growth, migration, and angiogenesis via Fbw7 and USP28-dependent degradation of HIF-1α. Blood (2011) 1.10

MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer. Int J Cancer (2013) 1.08

Fbw7 promotes ubiquitin-dependent degradation of c-Myb: involvement of GSK3-mediated phosphorylation of Thr-572 in mouse c-Myb. Oncogene (2009) 1.07

FoxO1 and HNF-4 are involved in regulation of hepatic glucokinase gene expression by resveratrol. J Biol Chem (2009) 1.07

Loss of USF transcriptional activity in breast cancer cell lines. Oncogene (1999) 1.07

Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor. Mol Cell Biol (2005) 1.02

An internal enhancer regulates heme- and cadmium-mediated induction of human heme oxygenase-1. Am J Physiol Renal Physiol (2003) 1.00

Transcriptional activation of the haem oxygenase-1 gene by cGMP via a cAMP response element/activator protein-1 element in primary cultures of rat hepatocytes. Biochem J (1998) 0.98

Recognition of the E-C4 element from the C4 complement gene promoter by the upstream stimulatory factor-1 transcription factor. J Immunol (1997) 0.98

Cell type-dependent regulation of the hypoxia-responsive plasminogen activator inhibitor-1 gene by upstream stimulatory factor-2. J Biol Chem (2005) 0.96

Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer. Int J Cancer (2012) 0.96

Isolation and initial characterization of the BRCA2 promoter. Oncogene (1999) 0.96

DNA-binding activity of the transcription factor upstream stimulatory factor 1 (USF-1) is regulated by cyclin-dependent phosphorylation. Biochem J (1999) 0.96

Target gene specificity of USF-1 is directed via p38-mediated phosphorylation-dependent acetylation. J Biol Chem (2009) 0.95

The upstream stimulatory factor-2a inhibits plasminogen activator inhibitor-1 gene expression by binding to a promoter element adjacent to the hypoxia-inducible factor-1 binding site. Blood (2001) 0.93

Upstream stimulating factor-1 (USF1) and USF2 bind to and activate the promoter of the adenomatous polyposis coli (APC) tumor suppressor gene. J Cell Biochem (2001) 0.89

Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis. J Pathol (2005) 0.88

Transcriptional regulation of plasminogen activator inhibitor-1 expression by insulin-like growth factor-1 via MAP kinases and hypoxia-inducible factor-1 in HepG2 cells. Thromb Haemost (2005) 0.86

The E-box binding factors Max/Mnt, MITF, and USF1 act coordinately with FoxO to regulate expression of proapoptotic and cell cycle control genes by phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3 signaling. J Biol Chem (2011) 0.86

Tumor-suppression function of transcription factor USF2 in prostate carcinogenesis. Oncogene (2006) 0.84

Suppression of tumorigenicity in the human prostate cancer cell line M12 via microcell-mediated restoration of chromosome 19. Genes Chromosomes Cancer (2001) 0.84

Structure, sequence, and chromosome 19 localization of human USF2 and its rearrangement in a patient with multicystic renal dysplasia. Genomics (1996) 0.83

Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells. Mol Carcinog (2005) 0.83

Role of upstream stimulatory factor phosphorylation in the regulation of the prostaglandin G/H synthase-2 promoter in granulosa cells. J Biol Chem (2005) 0.82

Opposite expression of the antioxidant heme oxygenase-1 in primary cells and tumor cells: regulation by interaction of USF-2 and Fra-1. Antioxid Redox Signal (2008) 0.81

PP2B-mediated dephosphorylation of c-Jun C terminus regulates phorbol ester-induced c-Jun/Sp1 interaction in A431 cells. Mol Biol Cell (2007) 0.81

Role of USF1 phosphorylation on cardiac alpha-myosin heavy chain promoter activity. Am J Physiol Heart Circ Physiol (2002) 0.80